132 related articles for article (PubMed ID: 1502896)
1. What do CA 125 and other antigens tell us about ovarian cancer biology?
Welander CE
Acta Obstet Gynecol Scand Suppl; 1992; 155():85-93. PubMed ID: 1502896
[TBL] [Abstract][Full Text] [Related]
2. The CA 125 tumour-associated antigen: a review of the literature.
Jacobs I; Bast RC
Hum Reprod; 1989 Jan; 4(1):1-12. PubMed ID: 2651469
[TBL] [Abstract][Full Text] [Related]
3. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
[TBL] [Abstract][Full Text] [Related]
4. [Value of CA 125 as a tumor marker in ovarian carcinoma].
Barrios CH; de P Guedes Neto E; Monteggia P; Fuhrmeister F; Basso A; Siqueira DP
Rev Assoc Med Bras (1992); 1995; 41(5):329-32. PubMed ID: 8731596
[TBL] [Abstract][Full Text] [Related]
5. CA 125 in the diagnosis of pelvic masses.
Mogensen O; Mogensen B; Jakobsen A
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1187-90. PubMed ID: 2767108
[TBL] [Abstract][Full Text] [Related]
6. CA 125 as a tumour marker in epithelial ovarian cancer.
Sheehan JD; Duffy MJ; Allen MA; Fennelly JJ
Ir J Med Sci; 1989 Jan; 158(1):10-3. PubMed ID: 2737852
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses.
Finkler NJ
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):105-7. PubMed ID: 8365503
[TBL] [Abstract][Full Text] [Related]
9. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
[TBL] [Abstract][Full Text] [Related]
10. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
[TBL] [Abstract][Full Text] [Related]
12. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
14. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
[TBL] [Abstract][Full Text] [Related]
15. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
Neunteufel W; Breitenecker G
Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
[TBL] [Abstract][Full Text] [Related]
16. The role of the CA 125 assay in the management of ovarian cancer.
Niloff JM
Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
18. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.
Breitenecker G; Neunteufel W; Bieglmayer C; Kölbl H; Schieder K
Int J Gynecol Pathol; 1989; 8(2):97-102. PubMed ID: 2714933
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
Knauf S; Bast RC
Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
